Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple tumor-associated antigens (TAAs) are molecules present at elevated levels on tumor cells, but also found at lower levels on normal cells. They include proteins, glycoproteins, oncofetal antigens, cancer-testis antigens, and altered cell surface molecules. TAAs play roles in cell growth, signaling, apoptosis, immune evasion, and stemness. They are used for diagnostic and therapeutic purposes, including targeted therapies and immunotherapies. Challenges include off-target toxicity due to expression in normal tissues.
Antibody-dependent cell-mediated cytotoxicity (ADCC), Complement-dependent cytotoxicity (CDC), Inhibition of receptor signaling
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Tumor-Associated Antigens (TAAs).